What are the antibodies of the acetylcholin receptor?

acetylcholine (ACH) receptor antibodies are proteins found in the blood of most people diagnosed myasthenia gravis (MG). These antibodies basically attack receptors in the nervous system in search of acetylcholine. The absence of antibody attacks does not exclude mg, but the presence of such attacks tends to confirm the disease. Chemicals also serve as a neurotransmitter in the brain that helps him function properly. The attack or destruction of oh would cause disconnection between muscles and nerve cells. In addition, the absence of oh would prevent the nerve nerve in the brain at the same time. Also, antibodies are also often found in patients who have neurological disorders other than Mg. Individuals who have been diagnosed with MG usually have about 50 percent the probability of developing acetylcholin receptor antibodies. In addition, individuals who have a serious Mg have about 90 % probability of developing antibodies. Less than 20 percent of patients diagnosed with mg have detectable antibody levelsacetylcholin receptors found in their bloodstream. The blocking antibody can lead to poor muscle contractions, but binding antibodies can lead to a loss of acetylcholine chemicals. Modulation antibodies cause the receptor endocytosis that means escalation of Mg.

One of the best ways to find out whether antibodies of acetylcholin receptor are present is testing on Mg. Like a typical blood test, a blood sample is taken from the patient and sent to the laboratory for evaluation. Using the reflex test algorithm, analysts consider the presence of binding antibodies of acetylcholin receptor in the bloodstream at a speed of more than 0.4 nanomoles per liter as serious. In such cases, treatment will be prescribed to prevent further development of the disease and damage to the nervous system.